Lodia Nutrition, Fermentalg join forces to develop the North American market

NEW YORK - March 1, 2021 - PRLog -- FERMENTALG is a leading European key player and expert in the research and bio industrial utilization of micro-algae in Bordeaux, France. Fermentalg has invested considerable resources in Research and Development and owns a quality of strain that yields a naturally high concentration of DHA, allowing the company to use gentle manufacturing processes without solvents.

This partnership will essentially gain access to a new portfolio of customers and grow its platform of Vegan Omega 3s (DHA ORIGINS®). This will also enable LODIA Nutrition to serve North American Food and Dietary Supplement industry with the highest natural concentration of Algal DHA on the market (550mg/g of DHA in its native Triglyceride form).

"This new partnership represents a significant step in Fermentalg's Sales Development. It strengthens our ability to promote our Vegan Omega 3 portfolio to new customers in North America to match our ambitions, specifically in the Dietary Supplement segment." says Philippe Lavielle, CEO of Fermentalg.
"We at Lodia are delighted to partner with Fermentalg, a leading international player in the Vegan DHA industry. Fermentalg' efforts to focus on traceability and sustainability while striving to have the lowest impact on the environment are unmatched and are a great fit to Lodia's vision.

Fermentalg has made significant investments to be able to produce a strain of Schizochytrium sp that naturally produces the highest levels of native DHA without the use of solvents or chemical engineering, which aligns with the current demand of clean label ingredients." said Olivier Guiot, founder and CEO of Lodia Nutrition.